 RNA-targeting small molecule drugs

RNA-targeting small molecule drugs are a class of therapeutics designed to selectively interact with RNA molecules in order to modulate their function and, consequently, influence biological processes associated with diseases. This approach aims to either enhance or inhibit the activity of specific RNA targets, such as mRNA, non-coding RNA (like siRNA and miRNA), or RNA structures, thereby affecting gene expression and cellular processes.